The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127290601 12729060 1 I 2015 20151130 20160909 20160909 EXP CA-SA-2015SA200480 AVENTIS 29.00 YR A F Y 63.00000 KG 20160909 OT CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127290601 12729060 1 PS LEMTRADA ALEMTUZUMAB 1 Intravenous (not otherwise specified) U F4002H11 103948 12 MG CONCENTRATE FOR SOLUTION FOR INFUSION QD
127290601 12729060 2 SS METHYLPREDNISOLONE. METHYLPREDNISOLONE 1 Intravenous (not otherwise specified) 0091014 0 1 G QD
127290601 12729060 3 SS ACYCLOVIR. ACYCLOVIR 1 Oral UNKNOWN 0 200 MG BID
127290601 12729060 4 C TYLENOL ACETAMINOPHEN 1 Oral Q4-6 PRN 836H 0 1 G
127290601 12729060 5 C RANITIDINE. RANITIDINE 1 Oral 0 150 MG BID
127290601 12729060 6 C DIMENHYDRINATE. DIMENHYDRINATE 1 Intravenous (not otherwise specified) Q4-6HR DKK327401 0 50 MG QD
127290601 12729060 7 C DIPHENHYDRAMINE. DIPHENHYDRAMINE 1 Intravenous (not otherwise specified) Q4-6HR 41121 0 50 MG QD
127290601 12729060 8 C VALACICLOVIR VALACYCLOVIR HYDROCHLORIDE 1 Oral 0 200 MG BID
127290601 12729060 9 C VITAMIN D CHOLECALCIFEROL 1 Oral 0
127290601 12729060 10 C BISOPROLOL BISOPROLOL 1 Oral 0
127290601 12729060 11 C EFFEXOR VENLAFAXINE HYDROCHLORIDE 1 Oral 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127290601 12729060 1 Relapsing-remitting multiple sclerosis
127290601 12729060 2 Premedication
127290601 12729060 3 Antiviral treatment
127290601 12729060 4 Premedication
127290601 12729060 5 Premedication
127290601 12729060 6 Premedication
127290601 12729060 7 Premedication
127290601 12729060 8 Antiviral treatment
127290601 12729060 11 Antidepressant therapy

Outcome of event

Event ID CASEID OUTC COD
127290601 12729060 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127290601 12729060 Autoimmune thyroiditis
127290601 12729060 Bacterial test
127290601 12729060 Blood thyroid stimulating hormone decreased
127290601 12729060 Feeling abnormal
127290601 12729060 Headache
127290601 12729060 Infusion site pain
127290601 12729060 Insomnia
127290601 12729060 Lymphocyte count decreased
127290601 12729060 Lymphocyte percentage decreased
127290601 12729060 Monocyte percentage increased
127290601 12729060 Muscular weakness
127290601 12729060 Neutrophil percentage increased
127290601 12729060 Pain in extremity
127290601 12729060 Specific gravity urine increased
127290601 12729060 Tri-iodothyronine free increased
127290601 12729060 Urinary sediment present
127290601 12729060 Urine abnormality
127290601 12729060 White blood cell count decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127290601 12729060 1 20151130 20151203 0
127290601 12729060 2 20151130 0
127290601 12729060 3 20151130 0
127290601 12729060 4 20151130 0
127290601 12729060 5 20151130 0
127290601 12729060 6 20151130 0
127290601 12729060 7 20151130 0
127290601 12729060 8 20151130 0